Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

<p>Effect of NKCEs targeting CD19 or CD20 on primary BCP-ALL cells. <b>A,</b> Phenotypic characterization via flow cytometry of four BCP-ALL primary leukemia samples, using CD45-APC-Vio770, CD19-PE-Cy7, and CD20-V450. <b>B,</b> 7AAD/AnnV staining of cells from sample AL...

保存先:

書誌詳細
第一著者:	Natalia Colomar-Carando (14611340) (author)
その他の著者:	Laurent Gauthier (15129623) (author), Pietro Merli (15129626) (author), Fabrizio Loiacono (5306981) (author), Paolo Canevali (332990) (author), Michela Falco (368897) (author), Federica Galaverna (8825531) (author), Benjamin Rossi (15129629) (author), Frédéric Bosco (15129632) (author), Mélody Caratini (15129635) (author), Maria Cristina Mingari (8409327) (author), Franco Locatelli (15127797) (author), Eric Vivier (48284) (author), Raffaella Meazza (7179467) (author), Daniela Pende (15129638) (author)
出版事項:	2025
主題:	Cancer Immuno-oncology Hematological Cancers Leukemias Immunology NK cells Immunotherapy Stem cell transplantation
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
著者:: Amir T. Fathi (15313195)
出版事項: (2025)

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
著者:: Amir T. Fathi (15313195)
出版事項: (2025)

Investigation on the Occurrence of Premature Ovarian Insufficiency after Allogeneic Haematopoietic Stem Cell Transplantation and Prognosis Analysis - a single-center real-world cross-sectional study
著者:: 辰宇石 (22420348)
出版事項: (2025)

Reducing Anxiety and Improving Adherence in Kidney Transplant Recipients: A Cognitive Behavioral Intervention -Based Approach
著者:: Chao Zhong (22679885)
出版事項: (2025)

<b>B lymphocytes impede Tregs to erode islet tolerance in Type 1 Diabetes</b>
著者:: Christopher S. Wilson (22462794)
出版事項: (2025)

Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 6 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Table 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Table 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Data Sheet 1_Glycocalyx kinetics and injury during liver procurement and transplantation as predictors of early graft dysfunction.docx
著者:: Nassiba Beghdadi (9577919)
出版事項: (2025)

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis
著者:: Rathana Kim (15135915)
出版事項: (2025)

Pearson correlations between willingness to participate in engagement and past participation in engagement.
著者:: Becca Beets (12878526)
出版事項: (2025)

Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
著者:: Sushil Kumar (20371917)
出版事項: (2025)

Cerebellar Purkinje cell (PC)-specific amyloid precursor protein (APP) expression modulates motor function.
著者:: Miao-Jin Ji (22676552)
出版事項: (2025)

A Guide to Creative Engagement in Public Spaces
著者:: Victoria Foster (21491630)
出版事項: (2025)

Reliability for the five sub-dimensions of past participation in engagement.
著者:: Becca Beets (12878526)
出版事項: (2025)

Descriptive statistics for five sub-dimensions of engagement activities.
著者:: Becca Beets (12878526)
出版事項: (2025)

Core Nature restoration
著者:: Fedorchenko (22513145)
出版事項: (2025)

Results of reliability tests for the five sub-dimensions of engagement activities.
著者:: Becca Beets (12878526)
出版事項: (2025)

Blog: Engaging with digital platforms for fundraising – a view from Montenegro
著者:: Milana Čergić (22674940)
出版事項: (2025)

Exogenous amyloid precursor protein (APP) expression restored the defects of the sIPSCs evoked by Nav1.6-mediated Purkenji cell inputs in APP-null mice.
著者:: Miao-Jin Ji (22676552)
出版事項: (2025)

Comparison of hierarchical classifier performance among four machine learning models for the early-loss, intermediate-loss, and late/no-loss groups.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Comparison of multi-class classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Comparison of binary classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Comparison of performance of four machine learning models for long-term graft loss prediction.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Comparison of prediction performance with previously reported metrics.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Comparison of performance of four machine learning models for early graft loss prediction.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Predicting stratified groups in the validation cohort: (A) Workflows for the multi-class classification and hierarchical classification models are illustrated.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Stratification and characterization of groups showing different graft survival: (A) UMAP visualization of the stratified derivation cohort data based on the distance matrix from the RF clustering.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Prediction of early graft loss at the individual level and identification of crucial factors: (A) Survival curves for all patients who experienced graft loss are plotted.
著者:: Raiki Yoshimura (22676573)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_on1sk2nssdss0j7bm6688ebkms